Proqr Therapeutics NV

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Proqr Therapeutics NV
TickerPRQR
CIK #0001612940
CUSIPN71542109
SectorLife Sciences - Pharmaceutical Preparations
AddressDarwinweg 24, Leiden, 2333CR
Source [EDGAR]
CIK Filing 2011 - 2024
[0001612940] 6-K
[0001612940] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Proqr Therapeutics NV [2022-02-09] 0.0
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10] 5.6
Wellington Management Group LLP Proqr Therapeutics NV [2019-11-08] 10.78
Inspirational Visions BV Proqr Therapeutics NV [2019-08-28] 5.1
RTW Investments LP Proqr Therapeutics NV [2019-02-22] 0.22
UBS Group AG Proqr Therapeutics NV [2019-02-15] 5.39
Goldman Sachs Group Inc Proqr Therapeutics NV [2019-02-07] 8.8
RTW Investments LP Proqr Therapeutics NV [2018-09-17] 5.05
Adage Capital Partners GP LLC Proqr Therapeutics NV [2018-05-25] 5.88
Aescap Medical Investments BV Proqr Therapeutics NV [2018-04-12] 5.6
Invus Public Equities LP Proqr Therapeutics NV [2018-02-09] 5.96
JDG BV Proqr Therapeutics NV [2017-10-11] 10.5
Invus Public Equities LP Proqr Therapeutics NV [2017-07-06] 6.0
Prudential Financial Inc Proqr Therapeutics NV [2016-04-11] 11.5
Jennison Associates LLC Proqr Therapeutics NV [2016-04-08] 11.5
OrbiMed Advisors LLC Proqr Therapeutics NV [2015-02-17] 3.75
Sofinnova Partners SAS Proqr Therapeutics NV [2015-02-17] 12.3
FMR LLC Proqr Therapeutics NV [2015-02-13] 0.0
Form 13F Holdings
Firm Period DFND Voting Shares
Privium Fund Management B.V. [2023-03-31] SOLE 5,344,446.0 5,344,446.0
Adage Capital Partners GP LLC [2023-03-31] SOLE 3,625,467.0 3,625,467.0
EcoR1 Capital LLC [2023-03-31] SOLE 2,902,715.0 2,902,715.0
M28 Capital Management LP [2023-03-31] SOLE 1,910,600.0 1,910,600.0
Millennium Management LLC [2023-03-31] SOLE 1,310,406.0 1,310,406.0
DAFNA Capital Management LLC [2023-03-31] SOLE 940,582.0 940,582.0
Opaleye Management Inc [2023-03-31] SOLE 653,000.0 653,000.0
Morgan Stanley [2023-03-31] DFND 628,810.0 648,858.0
Marshall Wace LLP [2023-03-31] OTR 0.0 626,926.0
Macquarie Group Ltd [2023-03-31] SOLE 620,000.0 620,000.0
Ikarian Capital LLC [2023-03-31] SOLE 472,625.0 472,625.0
Two Sigma Investments LP [2023-03-31] SOLE 417,927.0 417,927.0
Deutsche Bank AG [2023-03-31] DFND 0.0 385,208.0
Two Sigma Advisers LP [2023-03-31] SOLE 345,300.0 374,000.0
Susquehanna International Group LLP [2023-03-31] DFND 0.0 278,400.0
JPMorgan Chase & Co [2023-03-31] DFND 222,576.0 222,576.0
Citadel Advisors LLC [2023-03-31] DFND 217,779.0 217,779.0
UBS OConnor LLC [2023-03-31] DFND 180,000.0 180,000.0
Monaco Asset Management SAM [2023-03-31] SOLE 179,334.0 179,334.0
HRT Financial LP [2023-03-31] DFND 171,306.0 171,306.0
Bank of America Corp /DE/ [2023-03-31] DFND 0.0 152,931.0
Franklin Street Advisors Inc /NC [2023-03-31] DFND 150,000.0 150,000.0
Cubist Systematic Strategies, LLC [2023-03-31] DFND 0.0 101,003.0
Boothbay Fund Management LLC [2023-03-31] OTR 0.0 95,745.0
Virtu Financial LLC [2023-03-31] DFND 94,564.0 94,564.0
Occudo Quantitative Strategies LP [2023-03-31] SOLE 88,617.0 88,617.0
Simplex Trading LLC [2023-03-31] SOLE 86,152.0 86,152.0
Verition Fund Management LLC [2023-03-31] SOLE 63,847.0 63,847.0
Jane Street Group LLC [2023-03-31] DFND 55,868.0 55,868.0
Geode Capital Management LLC [2023-03-31] DFND 36,293.0 36,293.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com